v. 11 n. 3 (2020)

Visualizar v. 11 n. 3 (2020)
Publicado: 2020-09-30

Editorial

Revisões

  • The role of TRPM8 in the pathophysiology of migraine

    Eduardo de Almeida Guimarães Nogueira, Yara Dadalti Fragoso (Autor)
    57-60
    DOI: https://doi.org/10.48208/HeadacheMed.2020.17

  • CGRP: from history to clinical application - A review

    Afonso Henrique Aragao, Joel Sanabria Duarte, Daniel Benzecry Almeida, Ricardo Ramina (Autor)
    61-67
    DOI: https://doi.org/10.48208/HeadacheMed.2020.18

Relato de caso

  • Pseudotumor cerebri secondary to secondary hypoparathyroidism and association to Fahr´s Syndrome: a case report

    Patrick Giordanni Gomes Sampaio, Hiago Diniz Maracajá, Francielle Lopes de Araújo Batista, Virgínia Gabriela Nóbrega Figueiredo, Nátalia Meg Adijuto de Melo (Autor)
    68-71
    DOI: https://doi.org/10.48208/HeadacheMed.2020.19

Original

Artigo Comentado

  • Anti-CGRP monoclonal antibodies in chronic cluster headache

    Aline Turbino Neves Martins da Costa (Autor)
    77
    DOI: https://doi.org/10.48208/HeadacheMed.2020.21

  • Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans

    Fabíola Dach Éckeli (Autor)
    78
    DOI: https://doi.org/10.48208/HeadacheMed.2020.22